Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7323
    +0.0026 (+0.35%)
     
  • CRUDE OIL

    83.80
    +0.99 (+1.20%)
     
  • Bitcoin CAD

    88,378.94
    +1,110.62 (+1.27%)
     
  • CMC Crypto 200

    1,394.64
    +12.07 (+0.87%)
     
  • GOLD FUTURES

    2,344.30
    +5.90 (+0.25%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ

    15,611.76
    -100.99 (-0.64%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6823
    +0.0004 (+0.06%)
     

Stocks in play: Aphria Inc.

Has received a cultivation licence from Health Canada for Aphria Diamond, the Company's second Leamington, Ontario cannabis greenhouse facility, bringing an additional 1,300,000 square feet of production space with an annual growing capacity of 140,000 kg. Combined with the Company's Aphria One facility and its subsidiary Broken Coast Cannabis, the Company now has more than 2,400,000 square feet of cultivation space capable of reaching a total annualized production capacity of 255,000 kg. Aphria Inc. shares T.APHA are trading up $0.20 at $7.01.

READ: